Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [ [maximum depth reached] ] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-trace').style.display = (document.getElementById('cakeErr6802831ec672e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802831ec672e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-code').style.display = (document.getElementById('cakeErr6802831ec672e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-context').style.display = (document.getElementById('cakeErr6802831ec672e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802831ec672e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr6802831ec672e-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 37318, 'title' => 'Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'subheading' => '', 'description' => '<div align="justify"> -The Hindu<br /> <br /> <em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /> <br /> </em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /> <br /> Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /> <br /> A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /> <br /> India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /> <br /> Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Hindu, 7 September, 2018, https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4685436, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 37318, 'metaTitle' => 'LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'metaKeywords' => 'Multi-drug-resistant Tuberculosis (MDR-TB),Tuberculosis,Intellectual Property Rights,generic drugs,generic medicines,IPRs,Public Health', 'metaDesc' => ' -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves....', 'disp' => '<div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 37318, 'title' => 'Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'subheading' => '', 'description' => '<div align="justify"> -The Hindu<br /> <br /> <em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /> <br /> </em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /> <br /> Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /> <br /> A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /> <br /> India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /> <br /> Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Hindu, 7 September, 2018, https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4685436, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {}, (int) 4 => object(Cake\ORM\Entity) {}, (int) 5 => object(Cake\ORM\Entity) {}, (int) 6 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 37318 $metaTitle = 'LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan' $metaKeywords = 'Multi-drug-resistant Tuberculosis (MDR-TB),Tuberculosis,Intellectual Property Rights,generic drugs,generic medicines,IPRs,Public Health' $metaDesc = ' -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves....' $disp = '<div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan | Im4change.org</title> <meta name="description" content=" -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves...."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals — for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-trace').style.display = (document.getElementById('cakeErr6802831ec672e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802831ec672e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-code').style.display = (document.getElementById('cakeErr6802831ec672e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-context').style.display = (document.getElementById('cakeErr6802831ec672e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802831ec672e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr6802831ec672e-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 37318, 'title' => 'Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'subheading' => '', 'description' => '<div align="justify"> -The Hindu<br /> <br /> <em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /> <br /> </em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /> <br /> Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /> <br /> A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /> <br /> India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /> <br /> Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Hindu, 7 September, 2018, https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4685436, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 37318, 'metaTitle' => 'LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'metaKeywords' => 'Multi-drug-resistant Tuberculosis (MDR-TB),Tuberculosis,Intellectual Property Rights,generic drugs,generic medicines,IPRs,Public Health', 'metaDesc' => ' -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves....', 'disp' => '<div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 37318, 'title' => 'Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'subheading' => '', 'description' => '<div align="justify"> -The Hindu<br /> <br /> <em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /> <br /> </em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /> <br /> Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /> <br /> A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /> <br /> India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /> <br /> Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Hindu, 7 September, 2018, https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4685436, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {}, (int) 4 => object(Cake\ORM\Entity) {}, (int) 5 => object(Cake\ORM\Entity) {}, (int) 6 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 37318 $metaTitle = 'LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan' $metaKeywords = 'Multi-drug-resistant Tuberculosis (MDR-TB),Tuberculosis,Intellectual Property Rights,generic drugs,generic medicines,IPRs,Public Health' $metaDesc = ' -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves....' $disp = '<div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan | Im4change.org</title> <meta name="description" content=" -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves...."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals — for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-trace').style.display = (document.getElementById('cakeErr6802831ec672e-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr6802831ec672e-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-code').style.display = (document.getElementById('cakeErr6802831ec672e-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr6802831ec672e-context').style.display = (document.getElementById('cakeErr6802831ec672e-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr6802831ec672e-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr6802831ec672e-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 37318, 'title' => 'Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'subheading' => '', 'description' => '<div align="justify"> -The Hindu<br /> <br /> <em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /> <br /> </em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /> <br /> Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /> <br /> A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /> <br /> India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /> <br /> Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Hindu, 7 September, 2018, https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4685436, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 37318, 'metaTitle' => 'LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'metaKeywords' => 'Multi-drug-resistant Tuberculosis (MDR-TB),Tuberculosis,Intellectual Property Rights,generic drugs,generic medicines,IPRs,Public Health', 'metaDesc' => ' -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves....', 'disp' => '<div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 37318, 'title' => 'Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan', 'subheading' => '', 'description' => '<div align="justify"> -The Hindu<br /> <br /> <em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /> <br /> </em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /> <br /> Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /> <br /> A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /> <br /> India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /> <br /> Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Hindu, 7 September, 2018, https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4685436, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {}, (int) 4 => object(Cake\ORM\Entity) {}, (int) 5 => object(Cake\ORM\Entity) {}, (int) 6 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 37318 $metaTitle = 'LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar &amp; Anupama Srinivasan' $metaKeywords = 'Multi-drug-resistant Tuberculosis (MDR-TB),Tuberculosis,Intellectual Property Rights,generic drugs,generic medicines,IPRs,Public Health' $metaDesc = ' -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves....' $disp = '<div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals &mdash; for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan | Im4change.org</title> <meta name="description" content=" -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves...."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals — for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 37318, 'title' => 'Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan', 'subheading' => '', 'description' => '<div align="justify"> -The Hindu<br /> <br /> <em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /> <br /> </em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /> <br /> Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /> <br /> A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /> <br /> India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals — for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /> <br /> Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Hindu, 7 September, 2018, https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4685436, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 37318, 'metaTitle' => 'LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan', 'metaKeywords' => 'Multi-drug-resistant Tuberculosis (MDR-TB),Tuberculosis,Intellectual Property Rights,generic drugs,generic medicines,IPRs,Public Health', 'metaDesc' => ' -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves....', 'disp' => '<div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals — for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 37318, 'title' => 'Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan', 'subheading' => '', 'description' => '<div align="justify"> -The Hindu<br /> <br /> <em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /> <br /> </em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /> <br /> Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /> <br /> A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /> <br /> India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals — for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /> <br /> Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /> </div>', 'credit_writer' => 'The Hindu, 7 September, 2018, https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'ending-tb-jayalakshmi-shreedhar-anupama-srinivasan-4685436', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 4685436, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {}, (int) 1 => object(Cake\ORM\Entity) {}, (int) 2 => object(Cake\ORM\Entity) {}, (int) 3 => object(Cake\ORM\Entity) {}, (int) 4 => object(Cake\ORM\Entity) {}, (int) 5 => object(Cake\ORM\Entity) {}, (int) 6 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 37318 $metaTitle = 'LATEST NEWS UPDATES | Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan' $metaKeywords = 'Multi-drug-resistant Tuberculosis (MDR-TB),Tuberculosis,Intellectual Property Rights,generic drugs,generic medicines,IPRs,Public Health' $metaDesc = ' -The Hindu The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves....' $disp = '<div align="justify">-The Hindu<br /><br /><em>The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs<br /><br /></em>After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035.<br /><br />Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration.<br /><br />A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all.<br /><br />India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals — for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma.<br /><br />Please <a href="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true" title="https://www.thehindu.com/opinion/op-ed/ending-tb/article24884403.ece?homepage=true">click here</a> to read more. <br /></div>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
Ending TB -Jayalakshmi Shreedhar & Anupama Srinivasan |
-The Hindu
The disease cannot be eliminated without universal access to affordable, quality diagnostics and drugs After decades spent battling the scourge of tuberculosis (TB) in developing countries, 2018 might be the year that it is finally accorded the gravitas it deserves. On September 26, the UN General Assembly will, for the first time, address TB in a High-Level Meeting and likely release a Political Declaration, endorsed by all member nations, to galvanise investment and action to meet the global target of eliminating TB worldwide by 2035. Elimination, which means reducing the number to one case per million people per year, will be impossible without universal, equitable access to affordable, quality TB diagnostics and treatment for anyone who needs it. Much to the disappointment of global civil society, issues around access to diagnostics and drugs have been considerably diluted in the most recent draft of the Political Declaration. A critical omission is that countries may avail of the various flexibilities under the Trade-Related Aspects of Intellectual Property Rights; another is that countries may invoke the Doha Declaration to compulsorily license drugs for use in public health emergencies. Yet another is the option to de-link the pricing of new TB drugs from the costs incurred in their research and development. The latest draft is a watered-down version of the original that actively committed to upholding access to affordable generics for all. India has fought to retain its status as a maker and distributor of generic medicines, thereby protecting the right to health of people in developing countries. Indian patent law contains important provisions that help protect and promote public health goals — for example, by overcoming bids by big pharma to evergreen patents of old drugs, through compulsorily licensing for certain drugs, and by permitting pre- and post-grant opposition to patents to challenge unfair patenting practices by big pharma. Please click here to read more. |